SEC 13F Intelligence

Managers / Q3 2023 · view latest →

325 CAPITAL LLC

CIK 0001873893 · 757 THIRD AVENUE, 20TH FLOOR, NEW YORK, NY, 10017 · 212-376-5325

Reported Value
$121M
Q3 2023
Positions
8
Filings on Record
18
2019–present window
Filed
Nov 14, 2023
original filing

Summary

325 Capital LLC reported $121M in U.S.-listed holdings across 8 positions for Q3 2023.

The portfolio is heavily concentrated: ATRO alone accounts for 22.1% of reported value.

Compared with Q2 2023, the fund opened 0 new positions and exited 1.

Portfolio Metrics

Turnover
+3.6%
vs prior filed quarter
Largest Position
+22.1%
Astronics

Methodology: turnover is min(value bought, value sold) ÷ average reported value across the two quarters — value-based, so market moves inflate it slightly versus a share-based measure. Concentration and largest position are shares of the filing’s total reported value, options excluded. New/exited counts compare against the prior filed quarter. All figures derive solely from the fund’s 13F filings.

Reported Value by Quarter

13F Reported Value
Q4 ’21: $102MQ4 ’21Q1 ’22: $132MQ2 ’22: $108MQ3 ’22: $86MQ3 ’22Q4 ’22: $92MQ1 ’23: $114MQ2 ’23: $152MQ2 ’23Q3 ’23: $121MQ4 ’23: $202MQ1 ’24: $217MQ1 ’24Q2 ’24: $238MQ3 ’24: $236MQ4 ’24: $259MQ4 ’24Q1 ’25: $241MQ2 ’25: $253MQ3 ’25: $329MQ3 ’25Q4 ’25: $285MQ1 ’26: $274Mfilingsflow.com

Portfolio Composition

By security type
Common Stock: 100.0%
  • Common Stock · 100.0% · $121M

Quarter-over-Quarter Changes full breakdown →

vs Q2 2023 (amended baseline)

IssuerMoveShare ΔShares nowValue ΔValue now
QSIIEURNEXTGEN HEALTHCARE INCSOLD OUT1.14M0$19M$0
DSKEUSDDASEKE INCADDED+575.3K1.42M+$1M$7M
ASTHAPOLLO MED HLDGS INCADDED+103.2K592.8K+$3M$18M
ATROASTRONICS CORPHELD+01.69M$7M$27M
BTMDBIOTE CORPHELD+03.77M$6M$19M
TACTTRANSACT TECHNOLOGIES INCHELD+01.01M$3M$6M
BLBDBLUE BIRD CORPHELD+01.18M$1M$25M
MPAAMOTORCAR PTS AMER INCHELD+01.41M+$491,770$11M

Value changes conflate price moves with buying and selling — share changes are the real signal. Share counts are not split-adjusted.

Holdings — Q3 2023

8 positions
#IssuerClass% PortfolioValueShares
1ATROASTRONICS CORPhistory →COM22.11%$27M1.69M
2BLBDBLUE BIRD CORPhistory →COM20.86%$25M1.18M
3BTMDBIOTE CORPhistory →CLASS A COM15.91%$19M3.77M
4ASTHAPOLLO MED HLDGS INChistory →COM NEW15.09%$18M592.8K
5MPAAMOTORCAR PTS AMER INChistory →COM9.38%$11M1.41M
6DSKEUSDDASEKE INChistory →COM6.02%$7M1.42M
7TACTTRANSACT TECHNOLOGIES INChistory →COM5.36%$6M1.01M
851AAMERICAN PUB ED INChistory →COM5.27%$6M1.28M

Filing History

QuarterReported ValuePositionsFiledTypeLinks
Q1 2026$274M12May 15, 202613F-HRchanges · EDGAR ↗
Q4 2025$285M13Feb 17, 202613F-HRchanges · EDGAR ↗
Q3 2025$329M12Nov 14, 202513F-HRchanges · EDGAR ↗
Q2 2025$253M11Aug 14, 202513F-HRchanges · EDGAR ↗
Q1 2025$241M11May 15, 202513F-HRchanges · EDGAR ↗
Q4 2024$259M12Feb 14, 202513F-HRchanges · EDGAR ↗
Q3 2024$236M11Nov 14, 202413F-HRchanges · EDGAR ↗
Q2 2024$238M13Aug 14, 202413F-HRchanges · EDGAR ↗
Q1 2024$217M12May 15, 202413F-HRchanges · EDGAR ↗
Q4 2023$202M13Feb 14, 202413F-HRchanges · EDGAR ↗
Q3 2023$121M8Nov 14, 202313F-HRchanges · EDGAR ↗
Q2 2023$152M9Aug 14, 202313F-HRchanges · EDGAR ↗
Q1 2023$114M9May 15, 202313F-HRchanges · EDGAR ↗
Q4 2022$92M7Feb 14, 202313F-HRchanges · EDGAR ↗
Q3 2022$86M8Nov 14, 202213F-HRchanges · EDGAR ↗
Q2 2022$108M10Aug 15, 202213F-HRchanges · EDGAR ↗
Q1 2022$132M9May 16, 202213F-HRchanges · EDGAR ↗
Q4 2021$102M9Feb 14, 202213F-HRchanges · EDGAR ↗

13F filings are due up to 45 days after quarter end, so holdings shown here lag the fund’s current book. Source: original SEC filing on EDGAR ↗.